Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 37 studies | 37% ± 15% | |
pericyte | 31 studies | 33% ± 14% | |
smooth muscle cell | 17 studies | 33% ± 12% | |
endothelial cell of lymphatic vessel | 13 studies | 35% ± 12% | |
vein endothelial cell | 13 studies | 45% ± 21% | |
endothelial cell of vascular tree | 12 studies | 53% ± 18% | |
endothelial cell of artery | 9 studies | 31% ± 9% | |
astrocyte | 9 studies | 31% ± 9% | |
adipocyte | 8 studies | 32% ± 11% | |
capillary endothelial cell | 8 studies | 32% ± 14% | |
fibroblast | 6 studies | 22% ± 9% | |
oligodendrocyte precursor cell | 5 studies | 23% ± 7% | |
podocyte | 4 studies | 61% ± 19% | |
mesothelial cell | 4 studies | 33% ± 10% | |
hepatic stellate cell | 3 studies | 38% ± 19% | |
myofibroblast cell | 3 studies | 22% ± 5% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 26% ± 8% | |
basal cell | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
prostate | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4637.36 | 89 / 89 | 94% | 16.96 | 849 / 901 |
breast | 99% | 8695.25 | 454 / 459 | 85% | 6.06 | 946 / 1118 |
thymus | 94% | 3491.20 | 612 / 653 | 84% | 22.00 | 508 / 605 |
adrenal gland | 81% | 2089.47 | 209 / 258 | 90% | 7.04 | 207 / 230 |
lung | 97% | 6500.20 | 561 / 578 | 71% | 4.43 | 825 / 1155 |
prostate | 90% | 4220.96 | 221 / 245 | 74% | 3.96 | 372 / 502 |
ovary | 90% | 3198.56 | 162 / 180 | 74% | 7.41 | 318 / 430 |
intestine | 77% | 2689.00 | 743 / 966 | 83% | 5.20 | 439 / 527 |
esophagus | 74% | 3090.35 | 1076 / 1445 | 85% | 8.90 | 155 / 183 |
pancreas | 60% | 917.90 | 196 / 328 | 93% | 11.44 | 166 / 178 |
bladder | 90% | 4375.57 | 19 / 21 | 58% | 3.06 | 290 / 504 |
uterus | 98% | 5364.37 | 166 / 170 | 46% | 7.36 | 212 / 459 |
stomach | 53% | 1629.97 | 190 / 359 | 88% | 6.54 | 253 / 286 |
brain | 25% | 663.12 | 666 / 2642 | 93% | 10.36 | 656 / 705 |
adipose | 98% | 11983.94 | 1182 / 1204 | 0% | 0 | 0 / 0 |
skin | 32% | 686.80 | 572 / 1809 | 63% | 7.39 | 297 / 472 |
spleen | 91% | 1876.30 | 219 / 241 | 0% | 0 | 0 / 0 |
heart | 87% | 3980.86 | 752 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 4379.12 | 1143 / 1335 | 0% | 0 | 0 / 0 |
liver | 21% | 393.21 | 47 / 226 | 56% | 3.72 | 229 / 406 |
muscle | 62% | 1511.20 | 494 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 38% | 2.87 | 17 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.04 | 8 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045636 | Biological process | positive regulation of melanocyte differentiation |
GO_0009617 | Biological process | response to bacterium |
GO_0003179 | Biological process | heart valve morphogenesis |
GO_0030198 | Biological process | extracellular matrix organization |
GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
GO_0090673 | Biological process | endothelial cell-matrix adhesion |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0030318 | Biological process | melanocyte differentiation |
GO_0006508 | Biological process | proteolysis |
GO_0035909 | Biological process | aorta morphogenesis |
GO_0003229 | Biological process | ventricular cardiac muscle tissue development |
GO_0010596 | Biological process | negative regulation of endothelial cell migration |
GO_0015031 | Biological process | protein transport |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
Gene name | ADAMTS9 |
Protein name | ADAM metallopeptidase with thrombospondin type 1 motif 9 A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-) |
Synonyms | KIAA1312 |
Description | FUNCTION: Cleaves the large aggregating proteoglycans, aggrecan (at the '1838-Glu-|-Ala-1839' site) and versican (at the '1428-Glu-|-Ala-1429' site). Has a protease-independent function in promoting the transport from the endoplasmic reticulum to the Golgi apparatus of a variety of secretory cargos. . |
Accessions | C9JWI2 ENST00000459780.1 ENST00000295903.8 [Q9P2N4-4] ENST00000481060.2 ENST00000467257.5 H0Y859 A0A087WTS1 Q9P2N4 ENST00000498707.5 [Q9P2N4-3] |